hotspot -WSS

hotspot

author：knowledge 2025-09-29 23:27:17 - browse：96585

A pharmacy technician prepares prescriptions for packaging and shipping after being filled. health policy coverage from STAT — George Frey/Getty Images

WASHINGTON — Republicans and Democrats alike want to stop drug shortages from happening. The vexing question is how.

The White House and a whole host of government agencies oversee programs aimed at mitigating drug shortages, including the Food and Drug Administration, the Administration for Strategic Preparedness and Response, the White House Office of Science and Technology Policy, the Department of Defense, and the Department of Commerce.

The White House also has a new task force that is supposed to put together recommendations for fighting drug shortages, one it formed early this year in response to news of the worsening drug shortage crisis as the country began running out of an increasing number of chemotherapies. It has met with representatives from hospitals, drugmakers, pharmacies, and others in the drug supply chain to brainstorm solutions, but it’s not clear what it has in mind or when it will make those recommendations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： STAT Report: Patient voices and perspectives

WSS

Biogen says it will cut costs by $700 million, slash 1,000 jobs

How doctors’ personal politics affect patients

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

New Alzheimer's drugs heat up race for early detection blood tests

Superbugs, antibiotic resistance get scrutiny in congress

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

hotspot

hotspot

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

One Duchenne patient's bittersweet hope for new treatment

Drug repurposing or repositioning? The language matters

EU fines Illumina $475 million over Grail acquisition

Novavax promises a turnaround & Lilly roils the obesity market

EU fines Illumina $475 million over Grail acquisition

Apple is now the first public company to be valued at $3 trillion

What to watch for from Zogenix and Amicus clinical trials

explore

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Superbugs, antibiotic resistance get scrutiny in congress

Sickle cell gene therapy cures need to be accessible in Africa

Antibody drugs appear effective. Now can we make enough of them?

One Duchenne patient's bittersweet hope for new treatment

Vermont grapples with historic flooding as more rainstorms head for Northeast

entertainment

knowledge

entertainment

knowledge